348 related articles for article (PubMed ID: 7635785)
21. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
22. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
23. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
24. Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy.
Anker CJ; Cachoeira CV; Boucher KM; Rankin J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):704-12. PubMed ID: 19473779
[TBL] [Abstract][Full Text] [Related]
25. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
26. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
28. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
29. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
30. [The value of postoperative irradiation in endometrial cancer of pathohistologic stage I].
Kucera H; Vavra N; Weghaupt K
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):618-24. PubMed ID: 2777049
[TBL] [Abstract][Full Text] [Related]
31. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
32. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.
Townamchai K; Berkowitz R; Bhagwat M; Damato AL; Friesen S; Lee LJ; Matulonis U; O'Farrell D; Viswanathan AN
Gynecol Oncol; 2013 Apr; 129(1):18-21. PubMed ID: 23262378
[TBL] [Abstract][Full Text] [Related]
33. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
34. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels.
Sorbe B; Straumits A; Karlsson L
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1385-9. PubMed ID: 16029797
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
[TBL] [Abstract][Full Text] [Related]
36. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
Nguyen C; Souhami L; Roman TN; Clark BG
Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
[TBL] [Abstract][Full Text] [Related]
37. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
Hsu WL; Wu CJ; Jen YM; Yen SH; Lin KT; Ger LP; Kim RY
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1425-31. PubMed ID: 7635783
[TBL] [Abstract][Full Text] [Related]
38. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
39. [Adenocarcinoma of the endometrium. The role of vaginal brachytherapy in the therapeutic sequence].
Calais G; Vitu L; Descamps P; Fignon A; Reynaud-Bougnoux A; Body G; Lansac J; Le Floch O
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(1):101-6. PubMed ID: 2019710
[TBL] [Abstract][Full Text] [Related]
40. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
